1,396 Shares in UnitedHealth Group Incorporated $UNH Purchased by General Partner Inc.

General Partner Inc. bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, Holdings Channel reports. The fund bought 1,396 shares of the healthcare conglomerate’s stock, valued at approximately $512,000.

A number of other hedge funds have also modified their holdings of the company. Park National Corp OH lifted its holdings in shares of UnitedHealth Group by 10.5% during the 3rd quarter. Park National Corp OH now owns 1,852 shares of the healthcare conglomerate’s stock valued at $680,000 after purchasing an additional 176 shares in the last quarter. Horizons Wealth Management acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $37,000. Heartwood Wealth Advisors LLC bought a new position in UnitedHealth Group in the third quarter valued at approximately $1,641,000. Rockland Trust Co. increased its position in shares of UnitedHealth Group by 3.6% during the third quarter. Rockland Trust Co. now owns 2,683 shares of the healthcare conglomerate’s stock worth $985,000 after acquiring an additional 94 shares in the last quarter. Finally, Violich Capital Management Inc. lifted its position in UnitedHealth Group by 15.6% in the 3rd quarter. Violich Capital Management Inc. now owns 36,134 shares of the healthcare conglomerate’s stock valued at $13,264,000 after acquiring an additional 4,880 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $0.53 on Monday, hitting $371.37. The company’s stock had a trading volume of 1,722,073 shares, compared to its average volume of 7,358,003. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The stock’s 50 day moving average is $393.26 and its 200-day moving average is $377.68. The company has a market capitalization of $333.34 billion, a PE ratio of 23.90, a PEG ratio of 1.40 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the company posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Sanford C. Bernstein reissued an “outperform” rating and issued a $512.00 price objective (up from $492.00) on shares of UnitedHealth Group in a research report on Wednesday, September 2nd. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $466.00 to $516.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Oppenheimer upped their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research note on Tuesday, July 21st. Finally, Jefferies Financial Group raised their target price on shares of UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $465.75.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.